A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder - Concepedia

Concepedia

Publication | Open Access

A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder

DOI Full Paper Access

76

Citations

56

References

2016

Year

Daniel Umbricht, Marta del Valle Rubido, Eric Hollander, James T. McCracken, Frederick Shic, Lawrence David Scahill, Jana Noeldeke, Lauren Boak, Omar Khwaja, Lisa Squassante,

Neuropsychopharmacology

References

	Year	Citations

Page 1